Pexmetinib (ARRY-614) is an orally bioavailable dual p38 MAPK/Tie-2 inhibitor studied in acute myeloid leukemia and inhibits osteoclastogenesis and breast cancer-induced osteolysis via the P38/STAT3 signaling pathway.
Molecular Weight:
556.63
Purity:
99.66%
CAS Number:
[945614-12-0]
Formula:
C31H33FN6O3
Target:
p38 MAPK|||Autophagy|||Tie-2
T6934
* VAT and and shipping costs not included. Errors and price changes excepted